StemCells, Inc. Initiates Landmark Trial Targeting “Communication Highway” of the Brain (Business Wire via Yahoo! Finance)
November 23rd, 2009
PALO ALTO, Calif.—-StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease , a neurological disorder that primarily afflicts children.
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)